Alexander Stojadinovic Selected Research

Alexander Stojadinovic Research Topics

Disease

38	Neoplasms (Cancer) 12/2024 - 01/2002
20	Wounds and Injuries (Trauma) 01/2014 - 11/2007
18	Breast Neoplasms (Breast Cancer) 01/2014 - 07/2006
14	Colonic Neoplasms (Colon Cancer) 09/2015 - 06/2007
11	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2002
11	Colorectal Neoplasms (Colorectal Cancer) 06/2015 - 10/2010
9	Peritoneal Neoplasms 02/2017 - 11/2008
6	Adenocarcinoma 09/2014 - 07/2002
6	Carcinoma (Carcinomatosis) 09/2014 - 01/2002
5	Pain (Aches) 01/2017 - 07/2006
5	Shock 12/2016 - 09/2010
4	Burns 04/2012 - 02/2009
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 12/2013
3	Papillary Thyroid Cancer 03/2015 - 08/2009
3	Rectal Neoplasms (Rectal Cancer) 01/2014 - 09/2006
3	Dysphonia (Spastic Dysphonia) 04/2011 - 06/2008
3	Infections 08/2010 - 04/2009
3	Surgical Wound 04/2010 - 04/2009
3	Hypersensitivity (Allergy) 04/2009 - 12/2007
3	Ischemia 11/2007 - 06/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2023
2	Lung Neoplasms (Lung Cancer) 07/2023 - 07/2017
2	Postoperative Pain 01/2017 - 01/2013
2	Adenoma (Adenomas) 04/2013 - 01/2002
2	Carcinogenesis 04/2013 - 01/2013
2	Primary Hyperparathyroidism 01/2013 - 01/2012
2	Thyroid Neoplasms (Thyroid Cancer) 08/2012 - 02/2011
2	Thyroid Nodule (Nodule, Thyroid) 08/2009 - 05/2008
2	Laryngeal Nerve Injuries 07/2008 - 12/2002
2	Hypoxia (Hypoxemia) 01/2008 - 11/2007
1	Brain Neoplasms (Brain Tumor) 10/2023
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 02/2017

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 07/2017 - 03/2008
8	VaccinesIBA 12/2024 - 07/2006
8	Peptides (Polypeptides)IBA 09/2013 - 07/2006
7	Proteins (Proteins, Gene)FDA Link 12/2013 - 07/2002
6	CytokinesIBA 04/2010 - 01/2008
4	ParaffinIBA 01/2013 - 01/2002
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2012 - 07/2006
4	Protein Subunit VaccinesIBA 04/2009 - 07/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2011
3	Hematoxylin (Haematoxylon)IBA 09/2015 - 06/2007
3	Eosine Yellowish-(YS) (Eosin)IBA 09/2015 - 06/2007
3	Keratins (Keratin)IBA 09/2015 - 06/2007
3	RNA (Ribonucleic Acid)IBA 02/2015 - 04/2012
3	ElementsIBA 01/2014 - 11/2008
3	Messenger RNA (mRNA)IBA 09/2013 - 06/2002
3	Colloids (Colloid)IBA 08/2013 - 09/2009
3	Lidocaine (Xylocaine)FDA LinkGeneric 08/2013 - 09/2009
3	MicroRNAs (MicroRNA)IBA 01/2013 - 02/2011
3	Formaldehyde (Formol)FDA Link 01/2013 - 02/2012
3	HLA Antigens (Human Leukocyte Antigens)IBA 05/2012 - 10/2008
3	ChemokinesIBA 12/2009 - 03/2008
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 05/2012
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 12/2013
2	IodineIBA 03/2015 - 08/2003
2	Thyroglobulin FDA Link 03/2015 - 08/2012
2	Long Noncoding RNAIBA 01/2015 - 09/2014
2	Capsules (Microcapsules)IBA 11/2014 - 08/2012
2	SilverIBA 01/2014 - 01/2013
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 08/2013 - 09/2009
2	Radioisotopes (Radionuclides)IBA 08/2013 - 09/2009
2	SolutionsIBA 08/2013 - 09/2009
2	SulfurIBA 08/2013 - 09/2009
2	Parathyroid Hormone (Parathormone)IBA 01/2013 - 03/2006
2	DNA (Deoxyribonucleic Acid)IBA 02/2012 - 10/2010
2	Local Anti-Infective Agents (Antiseptics)IBA 01/2012 - 09/2010
2	Matrix Metalloproteinases (MMPs)IBA 04/2010 - 01/2008
2	Estrogen ReceptorsIBA 05/2009 - 11/2007
2	Immunoglobulin G (IgG)IBA 04/2009 - 10/2008
2	CXC ChemokinesIBA 02/2009 - 01/2008
1	AutoantigensIBA 12/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2024
1	Cancer VaccinesIBA 12/2024
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Circulating Tumor DNAIBA 07/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2017

Therapy/Procedure

32	Therapeutics 12/2024 - 02/2002
12	Thyroidectomy 03/2015 - 12/2002
11	Drug Therapy (Chemotherapy) 02/2017 - 07/2002
11	Extracorporeal Shockwave Therapy 12/2016 - 11/2007
7	Hyperthermic Intraperitoneal Chemotherapy 02/2017 - 01/2009
5	Cytoreduction Surgical Procedures 02/2017 - 11/2008
5	Aftercare (After-Treatment) 12/2016 - 01/2014
5	Debridement 01/2012 - 11/2007
4	Parathyroidectomy 03/2015 - 08/2009
4	Neoadjuvant Therapy 01/2014 - 07/2002
3	Operative Time 01/2017 - 01/2013
3	Adjuvant Chemotherapy 09/2015 - 05/2009
3	Negative-Pressure Wound Therapy 01/2011 - 12/2008
3	Catheters 05/2010 - 07/2006
2	Analgesia 01/2017 - 05/2010
2	Radiotherapy 01/2014 - 07/2002
2	Injections 05/2012 - 09/2009
2	Length of Stay 08/2010 - 04/2009
1	Local Anesthesia 01/2017